Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2024 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
October 29, 2024 07:46 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
October 29, 2024 07:45 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Eledon Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of Regimen Following Islet Transplantation
September 11, 2024 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
September 04, 2024 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplants
August 14, 2024 17:21 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
July 29, 2024 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
July 02, 2024 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
June 03, 2024 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
May 09, 2024 07:30 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right